{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:47:39Z","timestamp":1767134859503,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":32,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004400.pub2","type":"reference-entry","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T03:08:53Z","timestamp":1090379333000},"source":"Crossref","is-referenced-by-count":10,"title":["Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults"],"prefix":"10.1002","author":[{"given":"AC","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DP","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BJ","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,19]]},"reference":[{"key":"10.1002\/14651858.CD004400.pub2-BIB2|cit1","unstructured":"Mansmann G Lammertink J Hartmann P H\u00fcbel K Oberh\u00e4user F St\u00fctzer H A Randomized, Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor (G-CSF, Filgrastim) in Nonneutropenic Patients with Nosocomial Pneumonia"},{"key":"10.1002\/14651858.CD004400.pub2-BIB1|cit2","series-title":"Pneumologie","first-page":"S60","article-title":"Results of a randomised, placebo-controlled study on the use of Granulocyte colony stimulating factor (G-CSF) in nosocomial pneumonia (NP)","author":"Mansmann","year":"2001"},{"issue":"4","key":"10.1002\/14651858.CD004400.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/515694","article-title":"A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group","volume":"178","author":"Nelson","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004400.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315775","article-title":"A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia","volume":"182","author":"Nelson","year":"2000","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004400.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.CCM.0000048629.32625.5D","article-title":"Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis","volume":"31","author":"Root","year":"2003","journal-title":"Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004400.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1378\/chest.119.2.523","article-title":"Filgrastim in patients with pneumonia and severe sepsis or septic shock","volume":"119","author":"Wunderink","year":"2001","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD004400.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1365-2249.1998.00559.x","article-title":"Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia","volume":"112","author":"Hustinx","year":"1998","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"10.1002\/14651858.CD004400.pub2-BIB8|cit8","first-page":"91","article-title":"Combination of granulocyte colony-stimulating factor and antibacterial drugs for the treatment of ventilatory associated nosocomial pneumonia","volume":"16","author":"Meyanci","year":"2001","journal-title":"Middle Eastern Journal of Anaesthesiology"},{"issue":"1","key":"10.1002\/14651858.CD004400.pub2-BIB9|cit9","article-title":"Assessment of study quality. Cochrane Reviewers' Handbook 4.2.1 [updated December 2003]: Section 6","author":"Alderson","year":"2004","journal-title":"The Cochrane Library"},{"issue":"7","key":"10.1002\/14651858.CD004400.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD004400.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1378\/chest.120.5.1695","article-title":"Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data","volume":"120","author":"Azoulay","year":"2001","journal-title":"Chest"},{"issue":"24","key":"10.1002\/14651858.CD004400.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199512143332408","article-title":"Community-acquired pneumonia","volume":"333","author":"Bartlett","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004400.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00520-001-0312-5","article-title":"Therapeutic use of granulocyte and granulocyte-macrophage colony- stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis","volume":"10","author":"Berghmans","year":"2002","journal-title":"Supportive Care in Cancer"},{"issue":"10","key":"10.1002\/14651858.CD004400.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004400.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee","volume":"101","author":"Bone","year":"1993","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD004400.pub2-BIB16|cit16","article-title":"Optimal Search Strategy for RCTs. Cochrane Reviewers' Handbook 4.1.5 [Updated April, 2002]. Appendix 5c","author":"Clarke","year":"2002","journal-title":"The Cochrane Library [database on disk and CDROM]"},{"issue":"4","key":"10.1002\/14651858.CD004400.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/ajrccm.158.4.9803114","article-title":"Severe community-acquired pneumonia. Assessment of severity criteria","volume":"158","author":"Ewig","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004400.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0002-9343(93)90060-3","article-title":"Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay","volume":"94","author":"Fagon","year":"1993","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004400.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1378\/chest.103.2.547","article-title":"Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients","volume":"103","author":"Fagon","year":"1993","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD004400.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004400.pub2-BIB21|cit21","unstructured":"Foote M Personal communication (letter and e-mail)"},{"issue":"3","key":"10.1002\/14651858.CD004400.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections","volume":"16","author":"Garner","year":"1988","journal-title":"American Journal of Infection Control"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004400.pub2-BIB23|cit23","first-page":"3","article-title":"Granulocyte colony-stimulating factor: its potential role in infectious disease","volume":"13","author":"Hartung","year":"1999","journal-title":"AIDS"},{"issue":"8","key":"10.1002\/14651858.CD004400.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archsurg.1990.01410200141022","article-title":"Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice","volume":"125","author":"Hebert","year":"1990","journal-title":"Archives of Surgery"},{"key":"10.1002\/14651858.CD004400.pub2-BIB25|cit25","unstructured":"Kober T Engert A Personal communication (e-mail)"},{"key":"10.1002\/14651858.CD004400.pub2-BIB26|cit26","first-page":"A535","article-title":"Filgrastim (rHuG-CSF) enhances ciprofloxacin uptake and bactericidal activity of human neutrophils in vitro [abstract 535, American Thoracic Society meeting, May, 1996]","volume":"153","author":"McKenna","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004400.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm\/148.5.1418","article-title":"Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association","volume":"148","author":"Niederman","year":"1993","journal-title":"American Review of Respiratory Disease"},{"issue":"2","key":"10.1002\/14651858.CD004400.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/ajrccm.157.2.97-02039","article-title":"Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study","volume":"157","author":"Sanchez-Nieto","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004400.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1182\/blood.V86.4.1301.bloodjournal8641301","article-title":"Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure","volume":"86","author":"Smith","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD004400.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1445-5994.2002.00195.x","article-title":"An audit of the use of granulocyte colony-stimulating factor in septic shock","volume":"32","author":"Stephens","year":"2002","journal-title":"Internal Medicine Journal"},{"issue":"2","key":"10.1002\/14651858.CD004400.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood.V93.2.425","article-title":"Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis","volume":"93","author":"Weiss","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD004400.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1182\/blood.V88.6.1907.bloodjournal8861907","article-title":"Filgrastim (r-metHuG-CSF): the first 10 years","volume":"88","author":"Welte","year":"1996","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004400.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T00:00:00Z","timestamp":1176854400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004400.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:34:34Z","timestamp":1628530474000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004400.pub2"}},"subtitle":[],"editor":[{"given":"Allen C","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,7,19]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004400.pub2","relation":{},"subject":[],"published":{"date-parts":[[2004,7,19]]}}}